Education
About Us
Working with TipRanks
Follow Us
LifeMD (LFMD)
NASDAQ:LFMD
LFMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.99 - $15.84
Previous CloseN/A
Volume302.38K
Average Volume (3M)2.20M
Market Cap
$293.51M
Enterprise Value$592.74M
Total Cash (Recent Filing)$36.23M
Total Debt (Recent Filing)$22.05M
Price to Earnings (P/E)―
Beta1.40
Next Earnings
Nov 05, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding47,417,393
10 Day Avg. Volume1,412,765
30 Day Avg. Volume2,195,158
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.02
Enterprise Value/Revenue2.55
Enterprise Value/Gross Profit2.76
Enterprise Value/Ebitda69.31
Forecast
1Y Price Target
$15.00Price Target Upside142.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Financial PerformanceLifeMD's total revenue and Telehealth revenue in 4Q24 significantly exceeded projections, indicating strong company performance.
Product OfferingsLifeMD announced plans to offer broad, affordable, and streamlined access to Wegovy through NovoCare Pharmacy, which could bring additional subscribers to LifeMD’s platform and further drive topline sales.
Subscriber GrowthThe Telehealth active subscriber base grew by 27% year-over-year, highlighting the company's expanding customer reach.
Bears Say
Earnings GuidanceTop- and bottom-line miss in 2Q25; 2025 guidance lowered.
Revenue Growth RisksRisks include lower than projected growth of telehealth revenue, inability to acquire and retain new patients, and higher than expected competition, which could affect the company's performance.
LifeMD News
LFMD FAQ
What was LifeMD’s price range in the past 12 months?
LifeMD lowest stock price was $3.99 and its highest was $15.84 in the past 12 months.
What is LifeMD’s market cap?
LifeMD’s market cap is $293.51M.
When is LifeMD’s upcoming earnings report date?
LifeMD’s upcoming earnings report date is Nov 05, 2025 which is in 66 days.
How were LifeMD’s earnings last quarter?
LifeMD released its earnings results on Aug 05, 2025. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of -$0.008 by -$0.052.
Is LifeMD overvalued?
According to Wall Street analysts LifeMD’s price is currently Undervalued.
Does LifeMD pay dividends?
LifeMD does not currently pay dividends.
What is LifeMD’s EPS estimate?
LifeMD’s EPS estimate is -0.04.
How many shares outstanding does LifeMD have?
LifeMD has 47,417,393 shares outstanding.
What happened to LifeMD’s price movement after its last earnings report?
LifeMD reported an EPS of -$0.06 in its last earnings report, missing expectations of -$0.008. Following the earnings report the stock price went down -44.848%.
Which hedge fund is a major shareholder of LifeMD?
Currently, no hedge funds are holding shares in LFMD
LifeMD Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.00 (142.33% Upside)
$15.00 (142.33% Upside)
Blogger Sentiment
Bullish
LFMD Sentiment 85%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 471.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.8%
Last 30 Days ▲ 5.3%
Last 30 Days ▲ 5.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
20.66%
12-Months-Change
Fundamentals
Return on Equity
301.60%
Trailing 12-Months
Asset Growth
15.27%
Trailing 12-Months
Company Description
LifeMD
LifeMD (LFMD) is a telehealth company that specializes in providing a range of virtual healthcare services, primarily focusing on chronic disease management, sexual health, and weight loss. The company leverages advanced technology to connect patients with licensed healthcare providers, offering personalized treatment plans and medications that are delivered directly to patients' homes. LifeMD's core products include telehealth consultations, prescription medications, and subscription-based health programs, catering to the growing demand for convenient and accessible healthcare solutions.
LFMD Company Deck
LFMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
While LifeMD showcased strong growth in telehealth revenue and a strategic expansion into new healthcare segments, challenges in the weight management segment and RexMD's elevated customer acquisition costs led to a downward revision of financial guidance. The integration of AI and debt-free status are positive indicators, but the challenges faced balance out the highlights.View all LFMD earnings summariesLFMD Stock 12 Month Forecast
Average Price Target
$15.00
▲(142.33% Upside)
Technical Analysis
Orasure Technologies
―
Petmed Express
―
Walgreens Boots Alliance
―
Foghorn Therapeutics
―
Atea Pharmaceuticals
―
Ownership Overview
15.70% Insiders
8.84% Mutual Funds
8.76% Other Institutional Investors
57.35% Public Companies and
Individual Investors